As demand for specialty therapies continues to grow, immunoglobulin (Ig) products remain an important and evolving area of care for infusion providers.

Used across a range of disease states, immunoglobulin therapies support patients with complex clinical needs and continue to play a significant role in both infusion and specialty pharmacy settings. At the same time, providers face ongoing challenges related to product access, supply dynamics, operational planning, and changing market conditions.

Understanding the broader Ig landscape can help organizations make more informed decisions and better prepare for what’s ahead.

As immunoglobulin utilization expands, providers face evolving considerations around product availability, purchasing strategies, inventory planning, and patient care. Understanding the broader market can help organizations make more informed operational decisions. Read More >